AbbVie (ABBV) was granted FDA orphan designation for an antibody drug conjugate comprising monoclonal antibody anti-SEZ6 IgG1 antibody conjugated to a Top1 inhibitor as a treatment of small cell lung cancer, according to a post to the FDA website.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ABBV:
Questions or Comments about the article? Write to editor@tipranks.com